August 28, 2016 10:09 AM ET


Company Overview of Semafore Pharmaceuticals, Inc.

Executive Profile

Daniel F. Hoth M.D.

Acting Chief Medical Officer, Semafore Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 12 different industries.

See Board Relationships


Dr. Daniel F. Hoth, M.D., serves as an Acting Chief Medical Officer of Semafore Pharmaceuticals, Inc. Dr. Hoth serves as the President of Hoth Consulting, where he provides drug development and clinical trial consulting services to pharmaceutical and biotechnology companies. He serves as clinical and drug development veteran with more than 25 years of experience. Dr. Hoth served as the Senior Vice President and Chief Medical Officer at AXYS Pharmaceuticals, Inc., from ...

Corporate Headquarters

8496 Georgetown Road
Indianapolis, Indiana 46268

United States

Phone: 317-876-3075
Fax: 317-876-3272

Board Members Memberships

Director, Chairman of Corporate Governance and Nominating Committee, Chairman of Research and Development Committee and Member of Compensation Committee


Franklin & Marshall College
Georgetown University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Semafore Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at